CoChat

In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET

Open access
Thomsen, Majken B, Jacobsen, Jan, Lillethorup, Thea P, Schacht, Anna C, Simonsen, Mette, Romero-Ramos, Marina, Brooks, David J, Landau, Anne M · 2021 · Journal of Cerebral Blood Flow & Metabolism

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

The number of functionally active synapses provides a measure of neural integrity, with reductions observed in neurodegenerative disorders. [11C]UCB-J binds to synaptic vesicle 2A (SV2A) transmembrane protein located in secretory vesicles. We aimed to assess [11C]UCB-J PET as an in vivo biomarker of regional cerebral synaptic SV2A density in rat lesion models of neurodegeneration. Healthy anesthetized rats had [11C]UCB-J PET and arterial blood sampling. We compared different models describing [11C]UCB-J brain uptake kinetics to determine its regional distribution. Blocking studies were performed with levetiracetam (LEV), an antiepileptic SV2A antagonist. Tracer binding was measured in rodent unilateral acute lesion models of Parkinsonism and Huntington’s disease, induced with 6-hydroxydopamine (6-OHDA) and quinolinic acid (QA), respectively. [3H]UCB-J autoradiography was performed in postmortem tissue. Rat brain showed high and fast [11C]UCB-J uptake and washout with up to 80% blockade by LEV. [11C]UCB-J PET showed a 6.2% decrease in ipsilateral striatal SV2A binding after 6-OHDA and 39.3% and 55.1% decreases after moderate and high dose QA confirmed by autoradiography. In conclusion, [11C]UCB-J PET provides a good in vivo marker of synaptic SV2A density which can potentially be followed longitudinally along with synaptic responses to putative neuroprotective agents in models of neurodegeneration.

Overview

Integrity signals

Registry

Crossref · 10.1177/0271678x20931140

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 30 references

Research works printed but not linked: 2

  1. Bertoglio D, 2019, J Cereb Blood Flow Metab, ■
  2. Shiozaki T, 2000, J Nucl Med, 41, 1612

Cited by

See all 38

Metadata

Authors
Thomsen, M. B., Jacobsen, J., Lillethorup, T. P., Schacht, A. C., Simonsen, M., Romero-Ramos, M., Brooks, D. J., & Landau, A. M.
Affiliations
  • Aarhus University (DK)
  • Department of Biomedicine, Aarhus University, Aarhus, Denmark
Corresponding author
Landau, Anne M
Venue
Journal of Cerebral Blood Flow & Metabolism
Published
2020-06-14
Volume
41
Issue
4
Pages
819-830
ISSN
  • 0271-678X (ISSN-L)
  • 1559-7016
OpenAlex
W3033668013
Cited by
38
References
30
Citations by year
2025: 5 · 2024: 6 · 2023: 6 · 2022: 10 · 2021: 8 · 2020: 3
FWCI
3.28
Type
journal article
Language
en
Open access
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Cerebral Blood Flow & Metabolism (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
  • Aarhus Universitet
  • Aarhus Universitetshospital
  • Parkinsonforeningen
  • Lundbeckfonden (R165-2013-16034, R218-2016-1486)
  • H. Lundbeck A/S
  • UCB Pharma
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
[11C]UCB-J, striatal lesions, neurodegeneration, parkinsonism, Huntington's disease, 6-hydroxydopamine, quinolinic acid, levetiracetam, positron emission tomography
MeSH terms
Levetiracetam, Animals, Anticonvulsants, Autoradiography, Corpus Striatum, Female, Huntington Disease, Hydroxydopamines, Kinetics, Membrane Glycoproteins, Nerve Tissue Proteins, Parkinson Disease, Secondary, Synapses, Rats, Sprague-Dawley, Quinolinic Acid, Neuroprotective Agents, Radiopharmaceuticals, Positron-Emission Tomography, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET. https://app.cochat.ai/papers/10.1177/0271678x20931140
The paper
Thomsen, M. B., Jacobsen, J., Lillethorup, T. P., Schacht, A. C., Simonsen, M., Romero-Ramos, M., Brooks, D. J., & Landau, A. M. (2021). In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET. Journal of Cerebral Blood Flow & Metabolism. https://doi.org/10.1177/0271678x20931140

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.